ICON (ICLR) Competitors $150.82 +1.94 (+1.30%) Closing price 04:00 PM EasternExtended Trading$150.52 -0.29 (-0.20%) As of 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ICLR vs. MEDP, CRL, IQV, TCOM, RDDT, GIB, CPAY, TOST, AER, and GRABShould you be buying ICON stock or one of its competitors? The main competitors of ICON include Medpace (MEDP), Charles River Laboratories International (CRL), IQVIA (IQV), Trip.com Group (TCOM), Reddit (RDDT), CGI Group (GIB), Corpay (CPAY), Toast (TOST), Aercap (AER), and Grab (GRAB). ICON vs. Its Competitors Medpace Charles River Laboratories International IQVIA Trip.com Group Reddit CGI Group Corpay Toast Aercap Grab ICON (NASDAQ:ICLR) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends. Do insiders and institutionals hold more shares of ICLR or MEDP? 95.6% of ICON shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 44.0% of ICON shares are held by insiders. Comparatively, 20.3% of Medpace shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts recommend ICLR or MEDP? ICON currently has a consensus price target of $213.08, suggesting a potential upside of 41.28%. Medpace has a consensus price target of $344.82, suggesting a potential upside of 5.76%. Given ICON's stronger consensus rating and higher possible upside, analysts clearly believe ICON is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ICON 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.60Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21 Does the media prefer ICLR or MEDP? In the previous week, ICON had 1 more articles in the media than Medpace. MarketBeat recorded 7 mentions for ICON and 6 mentions for Medpace. Medpace's average media sentiment score of 0.82 beat ICON's score of 0.65 indicating that Medpace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ICON 1 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Medpace 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation and earnings, ICLR or MEDP? ICON has higher revenue and earnings than Medpace. ICON is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioICON$8.28B1.47$791.47M$9.1816.43Medpace$2.11B4.44$404.39M$13.1024.89 Which has more risk and volatility, ICLR or MEDP? ICON has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Is ICLR or MEDP more profitable? Medpace has a net margin of 19.31% compared to ICON's net margin of 9.25%. Medpace's return on equity of 54.36% beat ICON's return on equity.Company Net Margins Return on Equity Return on Assets ICON9.25% 11.46% 6.49% Medpace 19.31%54.36%20.81% SummaryICON beats Medpace on 9 of the 17 factors compared between the two stocks. Get ICON News Delivered to You Automatically Sign up to receive the latest news and ratings for ICLR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ICLR vs. The Competition Export to ExcelMetricICONMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.02B$7.29B$5.49B$8.93BDividend YieldN/A2.79%5.38%4.13%P/E Ratio16.4328.1026.2119.90Price / Sales1.4732.00405.84161.31Price / Cash7.4322.0136.4957.06Price / Book1.286.628.055.38Net Income$791.47M$230.16M$3.15B$248.50M7 Day Performance3.37%3.57%1.85%2.97%1 Month Performance17.01%5.73%4.81%6.02%1 Year Performance-52.62%33.35%34.86%20.39% ICON Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ICLRICON4.3963 of 5 stars$150.82+1.3%$213.08+41.3%-53.0%$12.02B$8.28B16.4341,900MEDPMedpace4.4543 of 5 stars$313.86+1.0%$344.82+9.9%-21.2%$9.02B$2.16B23.965,900CRLCharles River Laboratories International4.0308 of 5 stars$151.64+1.1%$171.85+13.3%-23.8%$7.45B$4.05B-233.2920,100Positive NewsIQVIQVIA4.8807 of 5 stars$157.69+0.1%$226.32+43.5%-22.0%$27.28B$15.41B21.4886,000Positive NewsTCOMTrip.com Group4.8962 of 5 stars$58.64-0.1%$77.25+31.7%+24.0%$38.31B$7.30B17.0033,700RDDTReddit2.1888 of 5 stars$150.74+5.4%$139.57-7.4%+129.1%$27.81B$1.30B255.502,233Trending NewsAnalyst ForecastGIBCGI Group3.8702 of 5 stars$104.93+1.5%$156.75+49.4%+6.8%$23.55B$10.79B19.1190,000Positive NewsCPAYCorpay3.9246 of 5 stars$332.07+1.5%$401.86+21.0%+27.3%$23.41B$3.97B23.2910,500Positive NewsAnalyst UpgradeTOSTToast2.8499 of 5 stars$44.33+1.0%$41.21-7.0%+69.2%$22.08B$4.96B192.744,500AERAercap2.5711 of 5 stars$116.96-0.2%$119.25+2.0%+25.0%$21.85B$8.06B10.38740Positive NewsGRABGrab1.7479 of 5 stars$5.03+2.2%$5.71+13.4%+39.7%$20.26B$2.80B251.639,490Trending News Related Companies and Tools Related Companies MEDP Alternatives CRL Alternatives IQV Alternatives TCOM Alternatives RDDT Alternatives GIB Alternatives CPAY Alternatives TOST Alternatives AER Alternatives GRAB Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ICLR) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Pentagon just made a National Security move...This "awesome resource" could power America for 30,000 years... We sent one of our smartest researchers.......Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ICON PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share ICON With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ICLR Stock Alerts